关于结构性心脏病的指导建议和证据水平的演变和区域差异
Yuxiang Tang1,2, Aijin Xie1,2, Yiming Yan3,4
1National Clinical Research Center for Cardiovascular Diseases, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100037, China.
iScience
|December 30, 2025
概括
结构性心脏病指南显示了强有力的建议,但往往缺乏高质量的证据. 区域差异仍然存在,这凸显了在制定临床指南方面需要全球合作的需要.
科学领域:
- 心脏病学 心脏病学
- 临床指南 临床指南
- 基于证据的医学基于证据的医学.
背景情况:
- 结构性心脏病 (SHD) 管理已取得显著进展.
- 不同地区的SHD指导方针的特点和演变尚未得到充分理解.
- 评估指南质量和区域差异对于改善患者护理至关重要.
研究的目的:
- 在SHD指南中分析推类和证据水平 (LOE) 的分布.
- 将这些特征与美国心脏病学会/美国心脏协会 (ACC/AHA),欧洲心脏病学会 (ESC) 和中国心血管学会进行比较.
- 评估SHD指南中的证据质量随着时间的推移而发生的变化.
主要方法:
- 从先前和当前的SHD指南中对1867条建议的系统评估.
- 根据类别 (强度) 和证据水平 (LOE A,B,C) 分类推.
- 对ACC/AHA,ESC和中国社会中的指南数据进行比较分析.
主要成果:
- 在目前的指南中,53.2%的建议是强烈的 (I/III类),但只有8.1%的LOE A.最高.
- 观察到区域差异:ACC/AHA指南主要使用LOE B (56.3%),而ESC和中国指南严重依赖LOE C (分别为79.4%和69.5%).
- 纵向分析表明,支持推的证据质量总体上有所改善.
结论:
- 在调整建议的强度与SHD指南中支持证据的质量方面存在着持续的挑战.
- 在证据利用方面存在显著的区域差异,需要国际合作来制定指导方针.
- 在全球范围内提高证据质量和标准化指南开发流程对于最佳的SHD管理至关重要.
相关概念视频
Pathophysiology of Heart Failure
2.6K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
2.6K
Heart Failure IV: Classification and Diagnostic Evaluation
281
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
281
Ischemic Heart Disease: Overview
2.7K
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
2.7K
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
435
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
435
Coronary Artery Disease II: Pathophysiology
332
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
332
Rheumatic Heart Disease III: Medical Management
261
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
261


